Goldman Sachs Sees 8% Upside At Dr. Reddy's
May 02, 2016 at 14:06 PM EDT
Goldman Sachs has started Dr.Reddy's Laboratories Ltd (ADR) (NYSE: RDY) with a Neutral rating; its price target of Rs.3,334.00 ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.